2016
DOI: 10.1177/2050640615601603
|View full text |Cite
|
Sign up to set email alerts
|

CT texture analysis in colorectal liver metastases: A better way than size and volume measurements to assess response to chemotherapy?

Abstract: Relative differences in CT texture occurring after treatment hold promise to assess the pathologic response to chemotherapy in patients with CRLMs and may be better predictors of response than changes in lesion size or volume.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
100
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
2
1

Relationship

0
7

Authors

Journals

citations
Cited by 108 publications
(110 citation statements)
references
References 29 publications
4
100
1
Order By: Relevance
“…Texture analysis of CT data is a 15 radiomics method [9][10][11] that can provide detailed quantitative characterization of local 16 variations in intensity levels throughout an image. Texture measures are computed from 17 regions of interest (ROI) drawn to delineate tumors on cross-sectional images. The local 18 texture can be measured using Haralick methods that quantify the second order intensity 19 variation within an ROI and other high-order features based on grey-level matrices [12].…”
Section: Author Summarymentioning
confidence: 99%
See 1 more Smart Citation
“…Texture analysis of CT data is a 15 radiomics method [9][10][11] that can provide detailed quantitative characterization of local 16 variations in intensity levels throughout an image. Texture measures are computed from 17 regions of interest (ROI) drawn to delineate tumors on cross-sectional images. The local 18 texture can be measured using Haralick methods that quantify the second order intensity 19 variation within an ROI and other high-order features based on grey-level matrices [12].…”
Section: Author Summarymentioning
confidence: 99%
“…The local 18 texture can be measured using Haralick methods that quantify the second order intensity 19 variation within an ROI and other high-order features based on grey-level matrices [12]. 20 Radiomics methods have been applied to evaluate intra-tumor heterogeneity based on a 21 single site of disease per patient in primary tumors [9,[13][14][15][16] and metastatic 22 disease [17][18][19]. However, a summary CT texture value for a single tumor site does not 23 capture the potential variability between different regions within the tumor and between 24 multiple tumor sites in the same patient.…”
Section: Author Summarymentioning
confidence: 99%
“…[25] Texture analysis technique can quantify the liver parenchyma so that provide more information about chemotherapy-induced changes. [26] In recent years, texture analysis has been confirmed to be helpful in predicting the response to chemotherapy for colorectal liver metastases. Rao et al [26] found relative differences after chemotherapy in Entropy and Uniformity (without filtration) in CT texture analysis may be better predictors of response to chemotherapy therapeutic effect in patients with colorectal liver metastases.…”
Section: Prediction Of Therapeutic Effect Of Primary Lesionsmentioning
confidence: 99%
“…[26] In recent years, texture analysis has been confirmed to be helpful in predicting the response to chemotherapy for colorectal liver metastases. Rao et al [26] found relative differences after chemotherapy in Entropy and Uniformity (without filtration) in CT texture analysis may be better predictors of response to chemotherapy therapeutic effect in patients with colorectal liver metastases. Non-responders showed increased Entropy and decreased Uniformity compared to responders in pre-treatment portal venous phase CT examination.…”
Section: Prediction Of Therapeutic Effect Of Primary Lesionsmentioning
confidence: 99%
“…CT texture analysis has been applied to patients with colorectal liver metastases, to investigate correlations with tumor grade, tumor response, or to predict recurrent disease. [47][48][49][50] Given the increasing number of patients with colorectal liver metastases undergoing locoregional therapies as well as liver resections with a wide range of outcomes, further investigations into the role of radiogenomics in this population are warranted.…”
Section: Livermentioning
confidence: 99%